ANAVEX LIFE SCIENCES CORP. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2016-09-30 was $5.00K.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2016-06-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2016-03-31 was $1.00.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for the quarter ending 2015-12-31 was $1.16K.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $6.16K, a 99.91% decline from fiscal 2015.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $6.76M, a 253.41% increase from fiscal 2014.
- ANAVEX LIFE SCIENCES CORP. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $1.91M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2016-09-30 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $6.16K 10-K · filed 2019-01-25 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-11 | |
| 2016-03-31 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-11 | |
| 2015-12-31 | $1.16K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $6.76M 10-K · filed 2017-12-11 | |
| 2014-09-30 | $1.91M 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |